|
|
|
|
| LEADER |
00000cam a22000004a 4500 |
| 001 |
6687051 |
| 003 |
ICU |
| 005 |
20081028102500.0 |
| 008 |
070809s2008 paua b 001 0 eng |
| 010 |
|
|
|a 2007033065
|
| 020 |
|
|
|a 9780781773287
|
| 020 |
|
|
|a 0781773288
|
| 035 |
|
|
|a 2007033065
|
| 035 |
|
|
|a (OCoLC)163708287
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d BAKER
|d C#P
|d YDXCP
|d VAM
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC271.C5
|b C446 2008
|
| 060 |
0 |
0 |
|a 2007 M-796
|
| 060 |
1 |
0 |
|a QZ 267
|b C5186 2008
|
| 082 |
0 |
0 |
|a 616.99/4061
|2 22
|
| 245 |
0 |
4 |
|a The chemotherapy source book /
|c editor, Michael C. Perry.
|
| 250 |
|
|
|a 4th ed.
|
| 260 |
|
|
|a Philadelphia :
|b Wolters Kluwer Health/Lippincott Williams & Wilkins,
|c c2008.
|
| 300 |
|
|
|a xvi, 779 p. :
|b ill. ;
|c 28 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Scientific basis of cancer chemotherapy -- Norton-simon hypothesis -- Drug resistance -- Principles of chemotherapy -- Clinical trials -- Hematopoietic growth factors -- Biologic response modifiers: principles of biotherapy -- Intraventricular and intrathecal therapy -- Intraperitoneal chemotherapy -- Continuous intravenous infusion chemotherapy -- Intraarterial chemotherapy -- Isolated regional therapy -- Hematopoietic stem cell transplantation -- Oral toxicity -- Dermatologic toxicity -- Extravasation -- Hypersensitivity reactions -- Ocular side effects of chemotherapy -- Cardiotoxicity of cancer therarpy -- Pulmonary toxicity of antineoplastic therapy -- Gastrointestinal complications of chemotherapy -- Hepatotoxicity of chemotherapeutic agents -- Renal and electrolyte abnormalities due to chemotherapy -- Chemotherapy-induced peripheral neuropathy -- Vascular toxicity of antineoplastic agents -- Second malignancies after chemotherapy -- Chemotherapy in pregnancy -- Gonadal complications and teratogenicity of cancer therapy -- Central venous access for chemotherapy -- Systemic therapy for advanced melanoma -- General issues in brain tumor chemotherapy -- Chemotherapy of head and neck cancer -- Chemotherapy of lung cancer -- Breast cancer -- Gastrointestinal cancer -- Endocrine tumors -- Chemotherapy of genitourinary cancers -- Chemotherapy of gynecologic cancers -- Chemotherapy of carcinoma of unknown primary site -- Chemotherapy of bone and soft tissue sarcomas -- Chemotherapy for pediatic solid tumors -- Chemotherapy of hodgkin's lymphoma -- Non-hodgkin's lymphoma -- Acute myeloid leukemia, aucte lymphoblastic leukemia, and chronic lymphocytic leukemia -- Chemotherapy of the myelodysplastic syndromes -- Management of myeloproliferative disorders and chronic myeloid leukemia -- Chemotherapy of multiple myeloma and other plasma cell disorders.
|
| 650 |
|
0 |
|a Cancer
|x Chemotherapy.
|0 http://id.loc.gov/authorities/subjects/sh85019497
|
| 650 |
|
0 |
|a Antineoplastic agents.
|0 http://id.loc.gov/authorities/subjects/sh85005714
|
| 650 |
1 |
2 |
|a Neoplasms
|x drug therapy.
|
| 650 |
2 |
2 |
|a Antineoplastic Agents
|x therapeutic use.
|
| 650 |
|
7 |
|a Antineoplastic agents.
|2 fast
|0 http://id.worldcat.org/fast/fst00810595
|
| 650 |
|
7 |
|a Cancer
|x Chemotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845327
|
| 700 |
1 |
|
|a Perry, Michael C.
|q (Michael Clinton),
|d 1945-
|0 http://id.loc.gov/authorities/names/n84026152
|1 http://viaf.org/viaf/27141798
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i f0b39969-d956-5fca-82f4-a3bf51c4a3fb
|s 0ee1d658-8247-58ae-8c51-f544ee1132c4
|
| 928 |
|
|
|t Library of Congress classification
|a RC271.C5 C446 2008
|l JCL
|c JCL-Sci
|i 6580277
|
| 927 |
|
|
|t Library of Congress classification
|a RC271.C5 C446 2008
|l JCL
|c JCL-Sci
|e BILL
|e CRERAR
|b 81590652
|i 8336242
|
